Related references
Note: Only part of the references are listed.Dual DNA topoisomerase 1 and tyrosyl-DNA phosphodiesterase 1 inhibition for improved anticancer activity
Alexandra Zakharenko et al.
MEDICINAL RESEARCH REVIEWS (2019)
Targeting Tyrosyl-DNA phosphodiesterase I to enhance toxicity of phosphodiester linked DNA-adducts
Evan J. Brettrager et al.
CANCER DRUG RESISTANCE (2019)
Mechanism-informed Repurposing of Minocycline Overcomes Resistance to Topoisomerase Inhibition for Peritoneal Carcinomatosis5\
Huang-Chiao Huang et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Protein-Protein Interactions in DNA Base Excision Repair
N. A. Moor et al.
BIOCHEMISTRY-MOSCOW (2018)
Novel group of tyrosyl-DNA-phosphodiesterase 1 inhibitors based on disaccharide nucleosides as drug prototypes for anti-cancer therapy
Anastasia O. Komarova et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2018)
Rare Genetic Diseases with Defects in DNA Repair: Opportunities and Challenges in Orphan Drug Development for Targeted Cancer Therapy
Sonali Bhattacharjee et al.
CANCERS (2018)
Sensitization of Cancer Cells to Radiation and Topoisomerase I Inhibitor Camptothecin Using Inhibitors of PARP and Other Signaling Molecules
Yusuke Matsuno et al.
CANCERS (2018)
Mechanisms of PARP inhibitor resistance in cancer and insights into the DNA damage response
Paola Francica et al.
GENOME MEDICINE (2018)
Dancing with the DNA damage response: next-generation anti-cancer therapeutic strategies
Anna Minchom et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2018)
DNA damage response and cancer therapeutics through the lens of the Fanconi Anemia DNA repair pathway
Sonali Bhattacharjee et al.
CELL COMMUNICATION AND SIGNALING (2017)
Tyrosyl-DNA phosphodiesterase inhibitors: Progress and potential
Sergey S. Laev et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2016)
Poly(ADP-ribose): From chemical synthesis to drug design
Mikhail S. Drenichev et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Synthesis and biological evaluation of novel tyrosyl-DNA phosphodiesterase 1 inhibitors with a benzopentathiepine moiety
Alexandra Zakharenko et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Poly(ADP-Ribose)-A Unique Natural Polymer Structural Features, Biological Role and Approaches to the Chemical Synthesis
Mikhail S. Drenichev et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2015)
Tyrosyl-DNA phosphodiesterase 1 is a new player in repair of apurinic/apyrimidinic sites
N. I. Rechkunova et al.
RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY (2015)
Clinical and Cellular Roles for TDP1 and TOP1 in Modulating Colorectal Cancer Response to Irinotecan
Cornelia Meisenberg et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Targeting DNA damage response in cancer therapy
Noriko Hosoya et al.
CANCER SCIENCE (2014)
Tyrosyl-DNA phosphodiesterase I resolves both naturally and chemically induced DNA adducts and its potential as a therapeutic target
Evan Q. Comeaux et al.
DRUG METABOLISM REVIEWS (2014)
Targeting DNA repair pathways for cancer treatment: what's new?
Mark R. Kelley et al.
FUTURE ONCOLOGY (2014)
The Selective Toxic Effect of Dialdehyde Derivatives of Pyrimidine Nucleosides on Human Ovarian Cancer Cells
A. S. Efremova et al.
BIOCHEMISTRY MOSCOW-SUPPLEMENT SERIES B-BIOMEDICAL CHEMISTRY (2014)
Inhibiting the DNA damage response as a therapeutic manoeuvre in cancer
N. J. Curtin
BRITISH JOURNAL OF PHARMACOLOGY (2013)
DISACCHARIDE PYRIMIDINE NUCLEOSIDES AND THEIR DERIVATIVES: A NOVEL GROUP OF CELL-PENETRATING INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE 1
Anna S. Efremova et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2013)
Tyrosyl-DNA Phosphodiesterase 1 Targeting for Modulation of Camptothecin-Based Treatment
G. L. Beretta et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Evolution of Poly(ADP-ribose) Polymerase-1 (PARP-1) Inhibitors. From Concept to Clinic
Dana V. Ferraris
JOURNAL OF MEDICINAL CHEMISTRY (2010)
PARP inhibition: PARP1 and beyond
Michele Rouleau et al.
NATURE REVIEWS CANCER (2010)
Synthesis of 2′-O-α-D-ribofuranosyladenosine, monomeric unit of poly(ADP-ribose)
Sergey N. Mikhailov et al.
TETRAHEDRON (2008)
Hereditary ataxia SCAN1 cells are defective for the repair of transcription-dependent topoisomerase I cleavage complexes
Ze-Hong Miao et al.
DNA REPAIR (2006)
Human Tdp1 cleaves a broad spectrum of substrates, including phosphoamide linkages
H Interthal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
'Green' methodology for efficient and selective benzoylation of nucleosides using benzoyl cyanide in an ionic liquid
AK Prasad et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2005)
SCAN1 mutant Tdp1 accumulates the enzyme-DNA intermediate and causes camptothecin hypersensitivity
H Interthal et al.
EMBO JOURNAL (2005)
Defective DNA single-strand break repair in spinocerebellar ataxia with axonal neuropathy-1
SF El-Khamisy et al.
NATURE (2005)
Engineered resistance to camptothecin and antifolates by retroviral coexpression of tyrosyl DNA phosphodiesterase-I and thymidylate synthase
MC Nivens et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2004)
TDP1 overexpression in human cells counteracts DNA damage mediated by topoisomerases I and II
HU Barthelmes et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Pathways for repair of topoisomerase I covalent complexes in Saccharomyces cerevisiae
JJ Pouliot et al.
GENES TO CELLS (2001)
Share Paper
